Encorafenib and Rotateq

• Generic Name: encorafenib
• Dosage Forms: n.a.
• Other Brand Names: Braftovi

Encorafenib is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Encorafenib is used in combination with another medicine called binimetinib (Mektovi) to treat melanoma (skin cancer) in people who have a "BRAF" gene mutation. These medicines are for use in treating melanoma that cannot be treated with surgery or has spread to other parts of the body.

Encorafenib may also be used for purposes not listed in this medication guide.

• Generic Name: rotavirus vaccine
• Dosage Forms: oral solution
• Other Brand Names: Rotarix, Rotateq, RotaShield

RotaTeq (rotavirus oral vaccine) contains up to five strains of rotavirus. It is made from both human and animal sources.

Infection with rotavirus can affect the digestive system of babies and young children, causing severe stomach or intestinal illness.

RotaTeq oral vaccine is used to help prevent this disease in children.

RotaTeq works by exposing your child to a small dose of the virus, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

RotaTeq is for use in children between the ages of 6 weeks and 32 weeks old.

Like any vaccine, RotaTeq may not provide protection from disease in every person.